This brand name is authorized in Albania, Austria, Estonia, Spain, France, Croatia, Ireland, Italy, Lithuania, Poland, Romania
The drug IFIRMACOMBI contains a combination of these active pharmaceutical ingredients (APIs):
|
1
Irbesartan
UNII 3OGC31WUMZ - IRBESARTAN HYDROCHLORIDE
|
|
Irbesartan is a potent, orally active, selective angiotensin-II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin-II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin-II. The selective antagonism of the angiotensin-II (AT1) receptors results in increases in plasma renin levels and angiotensin-II levels, and a decrease in plasma aldosterone concentration. |
|
2
Hydrochlorothiazide
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE
|
|
Hydrochlorothiazide is a diuretic with antihypertensive properties. It acts by inhibiting the renal tubular re-absorption of sodium and chloride ions, which are excreted with an accompanying volume of water. Potassium excretion is also promoted. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| C09DA04 | Irbesartan and diuretics | C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DA Angiotensin II antagonists and diuretics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: AL | Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor | Identifier(s): 566/73, 568/73 |
| Country: EE | Ravimiamet | Identifier(s): 1518915, 1518926, 1518937, 1518948, 1518959, 1518960, 1518971, 1518982, 1518993, 1519006, 1519017, 1519028, 1519039, 1519040, 1519051, 1519062, 1519073, 1519084, 1519095, 1519107, 1519118 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 11673002, 11673010, 11673018 |
| Country: FR | Base de données publique des médicaments | Identifier(s): 64018107, 65355223, 66500369 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 19630, 19671, 19723 |
| Country: IT | Agenzia del Farmaco | Identifier(s): 041633025, 041633102, 041633189 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1059557, 1059558, 1059559, 1059560, 1059561, 1059562, 1059563, 1059564, 1059565, 1059566, 1059567, 1059568, 1059569, 1059570, 1059571, 1059572, 1059573, 1059574, 1059575, 1059576, 1059577, 1059578, 1059579, 1059580 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100310619, 100310631, 100310648 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W57419001, W57419002, W57419003, W57419004, W57419005, W57419006, W57419007, W57419008, W57420001, W57420002, W57420003, W57420004, W57420005, W57420006, W57420007, W57420008, W57421001, W57421002, W57421003, W57421004, W57421005, W57421006, W57421007, W57421008 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
